Skip to main content
. 2002 Mar;76(6):2721–2729. doi: 10.1128/JVI.76.6.2721-2729.2002

FIG. 3.

FIG. 3.

Interaction between STAT-3 and FPV of HBV enhancer 1. The EMSA was carried out in the presence of 32P-labeled FPV probe and lysates from Huh-7 cells transfected with v-Src. Lanes 1 and 6, 5 μg of lysates as a source of STAT-3; lanes 2, 4, and 7, 100-fold excesses of wild-type FPV, STAT-3, and PBF oligonucleotides, respectively; lanes 3, 5, and 8, 100-fold excesses of mutant FPV, STAT-3, and PBF oligonucleotides, respectively; lanes 11 and 12, protein-DNA complex incubated with anti-STAT-3 and anti-HNF-3 serum, respectively.

HHS Vulnerability Disclosure